Skip to content
NEWSnet Boise
    • Homepage
Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types

Category: PRNewswire

Posted Date:

June 1, 2026
  • Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types

    Hengrui Pharma
    June 1, 2026
  • VINFAST AND AUTOBRAINS LAUNCH FIRST AGENTIC AI L4 PROGRAM FOR SOUTHEAST ASIA WITH NVIDIA

    VinFast
    June 1, 2026
  • MSI Accelerates Enterprise AI Strategy with Cloud-to-Edge Ecosystem at COMPUTEX 2026

    MSI
    May 31, 2026
  • Supermicro Introduces DCBBS Blueprints for NVIDIA Vera Rubin NVL72 and NVIDIA HGX™ Rubin NVL8, Built to Scale from 5MW to 1GW as an End-to-End Total Solution

    SUPER MICRO COMPUTER, INC.
    May 31, 2026
  • Unitree Announces H2 Plus, an NVIDIA Isaac GR00T Reference Humanoid Robot for Academic Research

    Unitree Robotics
    May 31, 2026
  • JA Solar Leads the Post‑Cycle PV Market with Dual‑Technology Breakthroughs and Integrated Solutions

    JA Solar Technology Co., Ltd
    May 31, 2026
Prev
1 … 468 469 470